Pelthos Therapeutics (PTHS) Stock Price & Financial Analysis
Pelthos Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Pelthos Therapeutics
What is the current stock price for PTHS?
As of the latest trading session, PTHS stock trades at $27.50. The 52-week range is $11.20–$54.29, with a day range of $26.47–$27.55.
What is the P/E ratio for PTHS?
The P/E ratio (Price-to-Earnings) for PTHS is shown in the Key Statistics section. This valuation metric helps compare Pelthos Therapeutics Inc. to industry peers.
Does PTHS pay dividends?
Pelthos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PTHS?
Based on 3 analysts, the consensus for PTHS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PTHS?
Pelthos Therapeutics's market capitalization is $51.7M, classifying it as a micro-cap company. Pelthos Therapeutics operates in the Healthcare sector within the Biotechnology industry.